Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.
about
Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy miceRisk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.A primer on arrhythmias in patients with hypertrophic cardiomyopathy.Arrhythmias in hypertrophic cardiomyopathy.[Clinical picture and therapy of hypertrophic cardiomyopathy]Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy.The prevention of sudden death in hypertrophic cardiomyopathy.Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.Device therapy in hypertrophic cardiomyopathy.Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.Sudden death due to atrial fibrillation in hypertrophic cardiomyopathy: a predictable event in a young patient.Sudden cardiac arrest in apical hypertrophic cardiomyopathy.Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death.Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.The prevalence and the prognostic value of microvolt T-wave alternans in patients with hypertrophic cardiomyopathy.High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy.Sudden, unexpected cardiac or unexplained death in England: a national survey.Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.Clinical Significance of Nonsustained Ventricular Tachycardia on Routine Monitoring of Pacemaker Patients.Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study
P2860
Q28592635-41ADB115-45D0-4D9D-89B7-1772859598ADQ33158326-073C1EFE-45D5-4320-B932-486DF2D5CE20Q33161569-DBB6A984-92DF-45BD-823C-D73162044D90Q33175408-40031363-6544-48BF-9BEA-3A66744CA89EQ33175633-76A7F791-714E-45A8-9363-0A5246F4E029Q34028344-B14C3A68-3952-4131-AB15-FA533EC81426Q34074592-BE470F93-3DE6-4219-A25A-A1A1B14034C9Q34628580-64331324-7315-48B4-BB48-867A4547C566Q35367410-6CEAC5AE-DEDB-49C5-B95B-1FD3FCDCCAF1Q36846820-C79BE439-3656-4598-8C4E-C19D000CC7DBQ36860996-D7C17CF4-44C6-4F2C-9767-2C697D566508Q37011369-E51AE1D7-335A-403B-9CA4-AD224200D272Q37603719-E3A030D8-0EBF-43AB-9B6B-F8E659CA3329Q37812384-5599C91A-4410-44E6-9FB1-662630F739F6Q38884022-2C90E4D0-E7FC-4BDF-AAA6-C246E5777A50Q39003149-DBCDFA0F-8F66-4E1A-A5F3-FD4AC352F8E8Q39747435-DF90B91B-6E5B-44F8-88D6-4917051C2705Q39801126-D195122C-CCFB-48C6-B357-E3F29A799004Q40591089-7A90C278-5F44-4016-8AD6-99311AA3C5E2Q41906819-7649FC36-A501-4729-A827-A6A35FE55E05Q44680690-38632176-345A-4002-9A84-58A859EACCB7Q44772159-647B44FC-EB46-4037-A0F8-5B750A10807DQ49044226-523B165E-0D78-4F36-B147-FCB2B0B345DAQ49366122-D665A33A-B678-4E17-B148-C14F6E0B7645Q50716468-870719B8-34E8-4DAA-B14E-4A0CB83816CCQ51536940-C02EDDF9-6450-472B-9286-8CF5C9287CD0Q51833897-CE155474-14CA-43FA-860E-F73BDA642E31Q53489965-26A7640E-F9A1-4918-8E30-31CFE1DCF9E6Q53572351-50AF6F6C-AC6A-4F2E-9C7D-E5895E8583A0Q57740179-7A9B793A-3F0B-4DAD-85A5-327D1349CB4C
P2860
Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Prognosis of asymptomatic pati ...... ained ventricular tachycardia.
@ast
Prognosis of asymptomatic pati ...... ained ventricular tachycardia.
@en
type
label
Prognosis of asymptomatic pati ...... ained ventricular tachycardia.
@ast
Prognosis of asymptomatic pati ...... ained ventricular tachycardia.
@en
prefLabel
Prognosis of asymptomatic pati ...... ained ventricular tachycardia.
@ast
Prognosis of asymptomatic pati ...... ained ventricular tachycardia.
@en
P2093
P356
P1433
P1476
Prognosis of asymptomatic pati ...... ained ventricular tachycardia.
@en
P2093
Chiarella F
Fragola PV
Ortolani P
Zoni-Berisso M
P304
P356
10.1161/01.CIR.90.6.2743
P407
P577
1994-12-01T00:00:00Z